Regeneron Chief Executive Leonard Schleifer hopes to file for approval by the end of 2004.

FORBES: Hunger Pangs

When Schleifer, a 50-year-old neurologist, cofounded Regeneron with George Yancopoulos , a molecular immunologist, the main target was Lou Gehrig's disease.

FORBES: Hunger Pangs

Slipher (the family name may have been from the German Schleifer ) was born in 1875 in Mulberry, Indiana where he grew up.

FORBES: A Giant In Hubble's Shadow

In the recently ended third quarter, Eylea captured roughly one-third of the branded market share for wet AMD, according to Regeneron ceo Leonard Schleifer.

FORBES: How The Compounding Scandal Benefits One Drugmaker